Clinical Side Effect Comparison: What the Evidence Shows
Side Effect of Wegovy vs Mounjaro: Understanding the Key Differences
The side effect profile of Wegovy differs significantly from Mounjaro due to their distinct mechanisms of action. Wegovy targets GLP-1 receptors exclusively, while Mounjaro acts on both GIP and GLP-1 receptors, potentially creating different gastrointestinal and metabolic effects. In the STEP trials, the most commonly reported side effects of Wegovy included nausea (44%), diarrhoea (30%), and vomiting (24%), typically occurring during dose escalation phases. These side effects are usually mild to moderate and transient, often diminishing as patients adjust to their prescribed dose over several weeks.
Mounjaro's dual receptor approach in the SURMOUNT trials showed similar gastrointestinal side effects, though some patients reported different tolerability patterns. The side effect of Wegovy versus Mounjaro may vary based on individual physiology, with some patients finding one more tolerable than the other. Both medications require gradual dose escalation specifically to minimise side effects, starting with lower doses and increasing over 16 weeks. Our clinical team at EverydayMeds monitors both treatments equally, ensuring you receive comprehensive support regardless of which prescription-only medicine your prescriber recommends.
Wegovy vs Mounjaro Pricing: Transparent Costs for Both Options
EverydayMeds offers competitive pricing for both Wegovy and Mounjaro, allowing you to choose based on clinical suitability rather than cost concerns. Wegovy starts at £79.99 for the 0.25mg starter dose with code FIRST40 for new customers, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenience for dose escalation, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, ensuring smooth treatment progression. Returning customers benefit from code DOSE25 applied at checkout, maintaining affordable access throughout their weight management journey.
Mounjaro pricing follows a similar structure with competitive rates across all six available doses from 2.5mg to 15mg maximum. Both medications include the same comprehensive service: 3-minute online clinical assessment, expert prescriber review, and next-day cold-chain delivery once approved. Our 2-pen and 3-pen bundle options provide treatment convenience, reducing order frequency whilst ensuring consistent supply. The side effect monitoring and clinical support included with both treatments represents exceptional value, with our GPhC-registered pharmacy team (#9012878) available throughout your treatment journey for guidance and reassurance.
Clinical Evidence: Side Effect of Wegovy in Major Trials
The STEP clinical programme, particularly the pivotal study by Wilding et al., NEJM, 2021, demonstrated that side effects of Wegovy are generally well-tolerated when managed appropriately. Most gastrointestinal side effects peaked during dose escalation periods and decreased significantly once patients reached their maintenance dose. The study showed that 7% of patients discontinued due to gastrointestinal side effects, indicating that the majority successfully adapted to treatment.
Comparative analysis suggests that the side effect profile of Wegovy remains consistent across diverse patient populations, including those with type 2 diabetes in STEP 2. MHRA's additional monitoring status ensures comprehensive UK safety surveillance, with our clinical team contributing to this ongoing assessment. Both Wegovy and Mounjaro maintain similar discontinuation rates due to side effects, suggesting comparable overall tolerability despite their different receptor targets.
How Wegovy's Mechanism Influences Its Side Effect Profile
Wegovy's selective GLP-1 receptor agonist action explains its characteristic side effect pattern, particularly the gastrointestinal effects that concern many patients. The medication mimics natural GLP-1 hormone, slowing gastric emptying and enhancing satiety signals to your brain's appetite centres. This mechanism directly affects digestive processes, which is why nausea, altered bowel habits, and early satiety are common initial experiences. The side effect of Wegovy relating to appetite reduction is actually part of its therapeutic action, helping patients feel satisfied with smaller portions. Most patients find these effects become manageable within 4-8 weeks as their digestive system adapts to the medication's presence. Understanding this mechanism helps explain why gradual dose escalation is essential for minimising side effects whilst achieving effective weight management.
Ordering Process: Expert Assessment for Both Wegovy and Mounjaro
EverydayMeds ensures safe prescribing of both Wegovy and Mounjaro through comprehensive clinical assessment, addressing side effect concerns before treatment begins. Our 3-minute online questionnaire captures your medical history, current medications, and specific concerns about potential side effects. Qualified prescribers review each application within 3 working days (24 hours with express service), considering your individual risk factors and treatment preferences. Once approved, both medications are dispatched via next-day delivery using temperature-controlled cold-chain transport to maintain medication integrity. Our clinical team provides ongoing support throughout treatment, monitoring for side effects and adjusting care as needed to optimise your experience with either prescription-only medicine.
Storage and Practical Considerations Affecting Side Effect Management
Proper storage significantly impacts medication effectiveness and side effect profiles, with Wegovy offering practical advantages for consistent dosing. Store Wegovy in your fridge at 2-8°C before first use, with the flexibility of 6 weeks at room temperature below 30°C once removed, compared to Mounjaro's 21-day room temperature limit. This storage flexibility helps maintain consistent dosing schedules, which is crucial for minimising side effects of Wegovy during travel or routine disruptions. Both medications use pre-filled FlexTouch or similar injection systems, ensuring accurate dosing that supports gradual tolerance development. The once-weekly dosing schedule for both treatments allows your body to adjust between doses, typically reducing the severity of gastrointestinal side effects over time. Consistent injection timing and proper storage practices significantly contribute to improved tolerability and reduced side effect intensity.
Side Effect Monitoring: Wegovy vs Mounjaro Safety Profiles Compared
The side effect monitoring approach for Wegovy versus Mounjaro requires understanding their distinct safety considerations and reporting patterns. Both medications carry MHRA Black Triangle status, ensuring enhanced safety surveillance and rapid identification of any emerging side effect patterns. Wegovy's longer UK market presence provides extensive real-world safety data, whilst Mounjaro's newer approval means continued intensive monitoring of its dual-receptor effects. Our clinical team tracks both medications equally, using standardised monitoring protocols to identify and manage side effects promptly.
Patient reporting suggests individual variation in side effect tolerance between the two treatments, with some finding Wegovy's GLP-1-only approach more suitable, whilst others prefer Mounjaro's dual-pathway mechanism. The side effect of Wegovy typically follows predictable patterns based on dose escalation, allowing proactive management strategies. Both treatments require similar monitoring frequency, with regular check-ins during the first 16 weeks being crucial for optimal side effect management and treatment success.
Making Your Choice: Wegovy vs Mounjaro Side Effect Considerations
Choosing between Wegovy and Mounjaro based on side effect profiles requires personalised clinical assessment rather than general comparisons. Your prescriber will consider your medical history, previous medication tolerances, and specific health conditions to determine which treatment may suit you better. EverydayMeds stocks both medications, ensuring your choice is based purely on clinical suitability rather than availability constraints. Our clinical team provides detailed side effect counselling for both options, helping you understand what to expect and how to manage any effects that arise. Both treatments include comprehensive support services, monitoring protocols, and flexible dosing adjustments to optimise your tolerance and treatment outcomes throughout your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
